Bryan Bryson

Bryan Bryson

@thebrysonlab.bsky.social

Tuberculosis, systems immunology, innate immunity, vaccines, computational biology. https://www.brysonlab.org/

1.8K followers1.3K following63 posts

Friends in the de novo binder protein design space -- if you've designed binders against cell surface proteins and then used them as flow cytometry reagents, I'd love to chat and compare notes!

Two pieces of fun news: 1. We've launched a new website for our lab: www.brysonlab.org 2. With some new funding, we are recruiting for new postdocs and graduate students. The projects build upon our previous studies of antigen presentation and phagosome biology and go into new exciting dimensions!

brysonlab.orgThe Bryson Lab | Vaccine Development & Research at MITDeveloping effective accessible vaccines to end tuberculosis worldwide. Combining immunoengineering, molecular microbiology & systems biology at MIT.

For postdoc candidates, please email me a CV and a cover letter. For graduate students, y'all know the processes for your appropriate departments and if you're not a graduate student yet, start getting your applications ready for next year's cycle!

View full thread
View full thread

So, we were stuck. Our data point to a role for ESX-1 in presentation but was it the secretion system or some other response that is downstream of ESX-1? So we did 2 experiments 1. We did discovery MS with macrophages infected with an ESX-1 mutant and asked if we could see Mtb-derived peptides. No!

2. For those of you who know Mtb, you'll know that Mtb mutants lacking the virulence lipid, PDIM, partially phenocopy ESX-1 mutants. We asked if PDIM mutants have a similar MHC-I phenotype. They didn't! This argues there is a specific role for the ESX-1 secretion system in MHC-I presentation

View full thread

OK, so ESX-1 controls galectin recruitment to the phagosome. Can we figure out a way to restore galectin positivity to the phagosome of an ESX-1 mutant? Yes, we used some previously identified small molecules and restored galectin positivity, but it did not rescue presentation.

View full thread

ESX-1 activity controls a lot in phagocytes, and we had previously demonstrated that the loss of presentation we saw was independent of interferon production. We still had a lot left to explore, and this preprint does just that.

We first tested an antigen expression hypothesis -- is the loss of presentation of Mtb-derived peptides on MHC-I explained by loss of expression of these antigens in the ESX-1 mutant in macrophages? No! If anything, we see elevated gene expression in the mutant.

In our previous paper, we showed that loss of ESX-1 disrupts presentation of Mtb-derived peptides on MHC-I using immunopeptidomics. Here, we first corroborated those findings using a T cell clone specific for one of the peptides we saw by MS.

We think this work is important because: 1. It helps us think about species differences in new ways 2. It highlights a metabolic gate in Mtb-host interactions 3. It may help resolve long-standing challenges in translating concepts from mouse studies to humans

So we took a step back and realized that in our hands human macrophages have more lipid droplets (LDs) at baseline than murine macrophages, so we tested the hypothesis that human LDs regulated the ability of Mtb to acquire and store lipids. Inhibition of host TAG synthesis did the trick (partially)!

Many of these Mtb genes were associated with lipid metabolism, so we orthogonally validated these observations by tracking Mtb acquisition and storage of lipids using established techniques and found that Mtb readily forms intracellular lipid inclusions in mouse but not human macrophages

We spent a full year trying to break the phenotype (macrophage culture media, macrophage and Mtb mutants) or small molecule perturbations (initially focusing on well-characterized species differences). TL, DR: these perturbations didn't do all that much

We often use mouse and human macrophages interchangeably to study Mtb-host interactions, but an open question in the field is how (if at all) different species impose unique stresses on intracellular Mtb

Here in work led by postdoc Jonathan Padilla-Gomez, we asked that question using an vitro model of Mtb infection of either primary human or mouse macrophages. To our surprise, we found many differentially expressed Mtb genes across host environments

We're super excited! These are needle in the haystack measurements out of the BL3 that Owen executed beautifully. These studies also provide us a path to antigen discovery and vaccine optimization in human cells. And it's generalizable -- we can definitely extend to other pathogens!

And importantly -- thank you to Owen, Forest White and our many amazing collaborators! Please get in touch if you want to chat more or have questions! And watch this space for the next two chapters of the Mtb-MHC saga (coming soon, they are very very exciting)

TL, DR: (1) Type VII secretion system substrates strike again -- enriched for presentation on MHC-II. (2) Lysosomal targeting enhances presentation on MHC-II by multiple orders of magnitude. (3) Coexpression of natural heterodimeric pairs can enhance presentation of Mtb-derived peptides.

Congrats to the Carpenter Lab on this exciting study! I might now sound like a broken record, but check the abstract!!! Let’s go type 7 secretion system substrates! #tuberculosis #tbsky

Stetsenko et al. show that TCR clonotypes from individuals latently infected w/ M. #tuberculosis demonstrate dominant but not exclusive recognition of infected #macrophages, specificity for type VII secretion system substrates, & expression of canonical effector programs rupress.org/jem/article/...

Bryan Bryson reposted

Newest paper from the lab out today (doi.org/10.1084/jem....)! Here, we describe PathMHC, a novel MS-based approach to identify rare pathogen-derived peptides on MHC-I and MHC-II. We apply this to a range of pathogens Mtb, SARS-CoV-2, and Listeria.

doi.orgTargeting infection-specific peptides in immunopeptidomics studies for vaccine target discoveryMS-based immunopeptidomics can facilitate vaccine antigen discovery, but self-MHC peptides greatly outnumber pathogen-derived MHC peptides, presenting a ch

Congrats to the amazing Owen Leddy for this tour de force which was inspired by reviewer comments from our previous paper and thanks to our amazing friends and collaborators for making the project a reality. And thanks to JEM for a very pleasant and efficient review process!

Pictured: glass of champagne I treated myself to at DCA upon learning the lab has been tenured! Grateful to my lab family, my extended science family, and my family for the amazing support and love offered on the journey so far. Much more work left to do but taking this moment to say thank you!

Do any of my #tbsky friends have interests in T cell responses in people with evidence of prior Mtb infection? If so, would you have any interest in looking at T cell responses to Mtb-derived peptides that we have detected by mass spectrometry? LMK 🙏🏽

Bryan Bryson reposted

So glad to see this out! I learned a lot in this project about how to think creatively about customizing our approach to using language models for immune receptors

Rohit Singh@rohitsingh8080.bsky.social

A bit over 3 years in the making, with first preprint out ~2 years ago, AbMAP has been a labor of love. Joint work with Chiho Im, an amazing MIT undergrad and now a fantastic Stanford grad student, and with Bonnie Berger and @thebrysonlab.bsky.social and @samsl.io and Lena Erlach and ...

What is your favorite cytosolic pathogen that (a) infects macrophages and (b) is genetically tractable? Looking for someone who’d like to team up on a small but impactful project (we would do the heavy lifting!)